Loading organizations...
Evariant is a technology company.
Evariant provides a comprehensive SaaS platform for healthcare consumer and physician engagement, optimizing growth for health systems. Its core offering integrates advanced analytics and CRM capabilities, enabling smarter patient acquisition, retention, and improved physician network utilization through actionable intelligence across the patient lifecycle.
William Moschella co-founded Evariant in 2008, recognizing a critical need for effective digital tools in healthcare patient engagement and physician alignment. He saw an opportunity to unify digital marketing, data, and analytics, modernizing how health systems connect with their communities.
Healthcare providers leverage Evariant's solutions to strengthen patient relationships and streamline operations. The company’s vision is to empower organizations to find, guide, and retain patients for life, reshaping the healthcare experience through data-driven engagement. This mission continues within Healthgrades, following its 2020 acquisition.
Evariant has raised $65.3M across 3 funding rounds.
Evariant has raised $65.3M in total across 3 funding rounds.
Evariant has raised $65.3M in total across 3 funding rounds.
Evariant's investors include Jason Kreuziger, CFA, DST Global, Floodgate, Founders Fund, Greylock, GSV Acceleration, Kapor Capital, Lightspeed Venture Partners, NextView Ventures, Sequoia Capital, Seven Seven Six, Sound Ventures.
Evariant is a healthcare technology company that built a leading CRM platform to help health systems improve patient acquisition, retention, and engagement.[1][2][3] Its Customer Success Platform, powered by Salesforce and advanced data analytics, enables providers to communicate care options effectively, driving revenue growth, market share expansion, and optimized network utilization for hospitals and healthcare systems.[1][2] The platform addresses key challenges like service line growth, extending patient lifetime value, and physician alignment, serving consumers, patients, and physicians.[1][3] Founded in 2008 and based in Farmington, Connecticut, Evariant raised $91.26M before being acquired by Healthgrades in January 2020, with its shareholders retaining a minority stake.[2]
Evariant was founded in 2008 in Farmington, Connecticut, as a provider of marketing automation and data integration services tailored to healthcare.[2][3] While specific founders are not detailed in available sources, the company emerged to tackle patient acquisition and retention in a fragmented healthcare market, leveraging predictive analytics and patient communications.[2] Early traction came from partnerships, notably with Salesforce, which powered its core platform for consumer engagement along the patient journey.[1] A pivotal moment arrived in January 2020 with its acquisition by Healthgrades, integrating Evariant's 30+ years of expertise in analytics to redefine provider-consumer relationships, with CEO Clay Ritchey highlighting successes in service line growth and network planning.[2]
Evariant stood out in healthcare CRM through these key strengths:
Evariant rode the wave of digital transformation in healthcare, particularly the shift toward patient-centric CRM amid rising consumer expectations for personalized care journeys.[1][2] Its timing aligned with the growth of cloud-based platforms like Salesforce in health systems, enabling data-driven engagement when electronic health records and telehealth were proliferating.[1][2] Market forces like value-based care and competition for patients favored its analytics for optimizing networks and revenue, influencing the ecosystem by setting standards for integrated marketing in hospitals.[3] Post-acquisition by Healthgrades, it amplified consumer-provider connections, contributing to broader trends in predictive analytics and improved health outcomes.[2]
Post-2020 acquisition, Evariant's platform likely continues evolving within Healthgrades, focusing on AI-enhanced patient journey tools amid trends like personalized medicine and digital health integration.[2] Rising demand for data privacy-compliant CRM and telehealth synergies will shape its path, potentially expanding influence through Healthgrades' consumer reach. As healthcare consolidates around outcome-driven tech, Evariant's legacy in patient-for-life strategies positions it to drive sustained growth in a market prioritizing engagement over transactions—echoing its original mission to transform experiences for health systems and patients.[1][3]
Evariant has raised $65.3M across 3 funding rounds. Most recently, it raised $42.0M Series C in November 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2015 | $42.0M Series C | Jason Kreuziger, CFA | DST Global, Floodgate, Founders Fund, Greylock, GSV Acceleration, Kapor Capital, Lightspeed Venture Partners, NextView Ventures, Sequoia Capital, Seven Seven Six, Sound Ventures, Streamlined Ventures, Theory Forge Ventures, True Ventures, Ulu Ventures, Uncork Capital, Y Combinator, Sam Altman, Health Enterprise Partners |
| May 1, 2014 | $18.0M Series B | Lightspeed Venture Partners | DST Global, Floodgate, Founders Fund, Greylock, GSV Acceleration, Kapor Capital, NextView Ventures, Sequoia Capital, Seven Seven Six, Sound Ventures, Streamlined Ventures, Theory Forge Ventures, True Ventures, Ulu Ventures, Uncork Capital, Y Combinator, Sam Altman, Dignity Health, Health Enterprise Partners, Salesforce Ventures |
| Nov 21, 2011 | $5.3M Other Equity | Dave Tamburri |